Stockman’s Casino Selects Quick Custom Intelligence Enterprise Platform
Markzware’s New App DesignMarkz™ Launches on Canva
Standards + Excelerate Copilots from Standards Core Now Available in the Microsoft Marketplace Â
ICARO Media Group Enters New Multiyear Digital Network Deal with Elevator Giant Otis in Spain, Portugal and Africa
John Snow Labs Selected to Showcase Healthcare Generative AI Innovations with AWS at RSNA 2025
Data show increased digital efficiency across most finance functions, but expanding responsibilities and diminishing resources…
AUSTIN, Texas & PARIS–(BUSINESS WIRE)–DentalMonitoring has launched a breakthrough service for dental professionals and industry…
AUSTIN, Texas & PARIS–(BUSINESS WIRE)–DentalMonitoring has launched a breakthrough service for dental professionals and industry…
TOKYO, Jul 21, 2022 – (JCN Newswire) – NEC Corporation (NEC; TSE: 6701) today announced…
TOKYO, Jul 21, 2022 – (JCN Newswire) – Fujitsu today announced that it conducted successful…
HONG KONG, Jul 21, 2022 – (ACN Newswire) – The PolyU DBA Alumni Association Limited…
TOKYO, Jul 21, 2022 – (ACN Newswire) – TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku,…
Company’s expansion is a complement to the region’s fast-growing startup ecosystem and progressive regulatory environment…
Digital Experience Analytics leader will use funding to scale innovation and propel market expansion as…
Cuts processing time by over 50%, energy consumption by up to 70% and CPU utilization…
London, United Kingdom, July 20, 2022 (GLOBE NEWSWIRE) — Virax Biolabs Group Limited (“Virax” or…
SAINT PETERSBURG, FL , Jul 21, 2022 – (ACN Newswire) – ESTN (https://estn.io) today announced…
– Peking Union Medical College Hospital Primary Clinical Trial Site BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge…
MEDFORD, Ore.–(BUSINESS WIRE)–PBCO Financial Corporation (OTC PINK: PBCO), the holding company of People’s Bank of…
CAMBRIDGE, Mass., July 20, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading…
Monthly information regarding the total number of voting rights and total number of shares of…
Company now focused on advancing lead clinical candidate mavorixafor in chronic neutropenic disorders, including WHIM syndrome…
Triple combination clinical trial evaluating AB-729, an RNAi therapeutic, vebicorvir, Assembly Biosciences’ core inhibitor, and…
DUBLIN, Ireland and FORT WASHINGTON, Pa., July 20, 2022 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc…
– Discontinues clinical development of vebicorvir, Assembly Bio’s first-generation core inhibitor, based on interim efficacy…